top of page
Search

A2A / Daewoong Pharmaceutical Oncology Agreement

  • Writer: A2A Pharma
    A2A Pharma
  • Feb 7, 2020
  • 1 min read

A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology Drug Discovery.





 
 
 

Recent Posts

See All
A2A Appoints New Advisors

Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE

 
 
 

Commentaires


bottom of page